Concepedia
Statistics
Publications
23
Citations
948
H-Index
16
Active since
1974
Affiliations
Pfizer (United Kingdom)(Current)
The University of Sydney
Institut Pasteur
Pfizer (United States)
University of Edinburgh
Richard Allan is an author at Pfizer (United Kingdom) specializing in pharmacology, pharmacy, and medicine.
Publications per year
1974–2021
Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
William MacNee, Richard Allan, Ieuan Jones et al. · Thorax · 2013 · 148 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease
Peter Braithwaite, Michael S. Roberts, Richard Allan et al. · European Journal of Clinical Pharmacology · 1982 · 96 citations
Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +7
Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot
Mathieu Mateo, Stéphanie Reynard, Xavier Carnec et al. · Science Translational Medicine · 2019 · 85 citations
Life Sciences, Immunology, Infectious Diseases +17
Plasmodium falciparum varies in its ability to induce tumor necrosis factor
Richard Allan, Dominic Kwiatkowski · Infection and Immunity · 1993 · 59 citations · Full text
Veterinary Medicine, Immunology, Infectious Diseases +15
The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms
Jeffrey R. Stokes, F.A. Romero, Richard Allan et al. · Journal of Allergy and Clinical Immunology · 2011 · 58 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +14
1–5 of 23